Welcome to our dedicated page for GENTEX SEC filings (Ticker: GNTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Gentex Corporation's SEC filings document recurring financial-reporting, governance and capital-allocation disclosures for an operating technology supplier. Recent Form 8-K reports furnish quarterly and annual earnings releases, including net sales, margins, operating income, share repurchases, and separate references to core Gentex results and VOXX contributions after the completed acquisition.
Proxy materials cover board elections, shareholder voting matters, executive compensation, equity awards and related governance disclosures. The filing record frames Gentex's public-company reporting around its digital vision, connected car, dimmable glass, fire protection, medical device and consumer electronics businesses.
A Rule 144 notice discloses a planned sale of 11,885 shares of common stock, with an aggregate market value of 296,848.08, through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ exchange around 02/17/2026.
The shares come from recent equity compensation: 6,317 shares acquired on 02/16/2026 via performance stock units and 5,568 shares from restricted stock vesting under a registered plan, both for services rendered. The seller represents they are not aware of any undisclosed material adverse information about the issuer.
A security holder of GNTX filed a Form 144 notice to potentially sell 35,000 shares of common stock through Morgan Stanley Smith Barney LLC on 02/17/2026, with an aggregate market value of $866,099.50. The filing notes that these 35,000 shares were acquired on 02/16/2026 as Performance Stock Units for services rendered. The notice also reports that 218,942,919 shares of this class were outstanding at the time, providing context for the size of the planned sale.
Gentex Corporation had an affiliated holder give notice of intent to sell up to 19,827 shares of its common stock under Rule 144. The planned sale, through Morgan Stanley Smith Barney LLC, has an aggregate market value of 496,170.68 and is listed for NASDAQ.
The shares come from recent equity compensation awards. On 02/16/2026, the seller acquired 15,705 shares via performance stock units and 4,122 shares from restricted stock vesting under a registered plan, both described as payment for services rendered.
A holder of GNTX common stock has filed a notice of proposed sale under Rule 144 for 9,024 shares, to be sold through Morgan Stanley Smith Barney LLC on or around 02/17/2026 on the NASDAQ, with an aggregate market value of $223,165.32.
The filing states that all of these shares were acquired on 02/16/2026 via vesting of 1,879 restricted stock units and 7,145 performance stock units granted by the issuer as compensation for services. Shares outstanding were 218,942,919 at the time referenced.
A shareholder of Gentex Corporation filed a notice of proposed sale under Rule 144 to sell 11,248 shares of common stock through Morgan Stanley Smith Barney on NASDAQ, with an approximate sale date of 02/17/2026 and an aggregate market value of $279,175.36.
The notice shows that these shares were acquired on 02/16/2026 via 2,332 restricted stock units vesting under a registered plan and 8,916 performance stock units, both paid for in cash. Gentex had 218,942,919 shares outstanding at the time, providing context for the size of the planned sale.
Wellington Management Group LLP and related entities report beneficial ownership of 2,300,392 Gentex Corporation common shares, representing about 1.05% of the class. All voting and dispositive power is shared, with no sole authority reported. The securities are held on behalf of Wellington investment advisory clients.
The filing notes Wellington’s stake is below 5% of Gentex’s outstanding common stock and that no individual client is known to hold more than 5% of the class. Wellington certifies the position is held in the ordinary course of business and not to change or influence control of Gentex.
Gentex Corporation filed a current report to make investors aware that it has released its latest financial results. The company issued a news release covering its fourth quarter and full year ended December 31, 2025, dated January 30, 2026.
The news release is provided as Exhibit 99.1 and is being furnished under the rules for results of operations and financial condition, rather than filed for liability purposes under Section 18 of the Exchange Act. The report is signed on behalf of Gentex by Kevin C. Nash, Vice President - Finance and Chief Financial Officer.
Gentex Corporation (GNTX) filed its Q3 2025 Form 10‑Q, reporting steady top‑line growth with net sales of $655,236,055, up from $608,525,777 a year ago. Quarterly net income was $100,967,910, and diluted EPS was $0.46.
For the first nine months, sales reached $1,889,867,355 with net income of $291,881,539. Operating cash flow was strong at $461,627,573, while the company invested in capacity and deals, including the April 1 consolidation of VOXX. Gentex recognized $8.4 million in other‑than‑temporary impairment charges on technology investments and increased its credit loss allowance by $4.8 million. The company amended its unsecured revolver to $350.0 million on October 2, 2025. It returned capital via dividends of $0.12 per share in Q3 and repurchased $230,450,683 of stock year‑to‑date. Cash and cash equivalents were $178,589,422 at quarter‑end, and shares outstanding were 218,942,919 as of October 24, 2025.
Gentex Corporation furnished an Item 2.02 Form 8‑K announcing financial results for the third quarter ended September 30, 2025, and attached a news release as Exhibit 99.1. The report is dated October 24, 2025.
The company stated that the information in this report and its exhibit is furnished and not deemed filed for purposes of Section 18 of the Exchange Act. The filing also lists Item 9.01 for the exhibit index, with the press release identified as Exhibit 99.1.
Kevin C. Nash, Chief Financial Officer and Director of Gentex Corporation (GNTX), reported a transaction dated 08/26/2025 affecting his holdings. The filing shows 865 shares disposed of Common Stock at a price of $28.28 per share. After the reported transaction, Mr. Nash beneficially owned 54,304 shares directly. The form includes an explanatory note stating the shares were purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan. The Form 4 was signed on behalf of Mr. Nash by a power of attorney on 08/27/2025. No derivative securities or additional transactions are reported in this filing.